Articles
Media
All VideosCase Based Roundtable SeriesEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsViewpoints
Publications
Digital EditionSupplements And Featured Publications
Conferences
Conference Listing
More
CME/CE
Resources
SponsoredZEISS Clinical CasesZeiss Cataract InsightsZeiss Cataract DigitalizationEnhancing the Patient JourneyEYLEA 8mg for nAMD and DME TreatmentBetween the Lines

Subscribe

  • Articles
  • Media
  • Publications
  • Conferences
  • CME/CE
  • Resources
  • Subscribe
  • AMD
  • Cataract & Refractive
  • Cornea
  • Gene Therapy
  • Glaucoma
  • Inflammation & Infection
  • Paediatrics
  • Retina
Spotlight -
ZEISS Clinical Cases|
Heidelberg Engineering: Enhancing the Patient Journey
Advertisement

Sibylle Scholtz, PhD

Advertisement

Articles by Sibylle Scholtz, PhD

A surgical tray sits on a dirt road. There are visible scalpels and other metal tools. Concept image for ocular trauma, conflict and combat zones, eye surgery and emergency ophthalmology in low-resource, high-conflict regions or war zones. Created by Jennifer Toomey using Adobe Firefly AI.

Clinicians keep their eyes on wartime ocular trauma

ByOksana Vitovska, MD, Sibylle Scholtz, PhD,Hattie Hayes
August 18th 2025

Every day brings a new challenge for surgeons in low-resource areas and conflict zones

Advertisement

Latest Updated Articles

  • A surgical tray sits on a dirt road. There are visible scalpels and other metal tools. Concept image for ocular trauma, conflict and combat zones, eye surgery and emergency ophthalmology in low-resource, high-conflict regions or war zones. Created by Jennifer Toomey using Adobe Firefly AI.
    Clinicians keep their eyes on wartime ocular trauma

    Published: August 18th 2025 | Updated:



Advertisement
Advertisement

Trending on Ophthalmology Times Europe

1

FLORetina: Inadvertent anti-VEGF interval increases during the COVID-19 pandemic

2

FLORetina 2025: AI in practice, discussed by Marion Munk and Quan Dong Nguyen

3

FLORetina 2025: A second Müller glial cell type in the human fovea

4

Dompé enrolls first patients in phase 3 trial of Isocyclosporin for atopic keratoconjunctivitis

  • Advertise
  • About Us
  • Editorial Info
  • Editorial Board
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us